Spider angiomas in patients with liver cirrhosis: Role of vascular endothelial growth factor and basic fibroblast growth factor

Table 3 Clinical features of cirrhotic patients with and with-out spider angiomas

Parameters	Spider (+) (n = 31)	Spider (-) (n = 55)	P Value
Age (years)	54 ± 2	66 ± 1	< 0.001
Sex (male/female)	27/4	41/14	0.17
Albumin (g/dL)	3.4 ± 0.1	3.5 ± 0.1	0.69
Creatinine (mg/dL)	1.0 ± 0.1	1.1 ± 0.1	0.24
AST (U/L)	91 ± 9	89 ± 13	0.93
ALT (U/L)	59 ± 9	72 ± 11	0.36
Platelet count (/uL)	108097 ± 12 379	94762 ± 7 541	0.33
Esophageal varices (nil/F1/F2/F3)	7/6/12/6	18/12/14/11	0.88
Child-Pugh score	8.2 ± 0.5	7.3 ± 0.3	0.99
Bilirubin (mg/dL)	3.1 ± 0.5	1.7 ± 0.2	0.03
Prothrombin time (s)	16.6 ± 0.7	14.8 ± 0.4	0.015
Alcoholism	14 (45%)	11 (20%)	0.014

AST = aspartate transaminase, ALT = alanine transaminase.